Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,859
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: New York NY, Baltimore MD, Charlottesville VA,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase1, Phase2, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: New Haven CT, New York NY, Fairfax VA, Cleveland OH,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase1, Recruiting
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
for
Heart Failure With Reduced Ejection Fraction
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 65+
Code: NCT05609097
Recruiting
Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
for
Intrauterine Growth Retardation
Location: New Hyde Park NY, Richmond VA, Cincinnati OH
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 1 - 18
Code: NCT00005105
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Roslyn NY, Valhalla NY, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Location: Fairfax VA, Sarasota FL, Nashville TN, St Louis MO,
Sponsor: Angiex, Inc.
Sex: All
Age: 18+
Code: NCT06440005
Phase1, Recruiting
MYLUNG Consortium Part 3: Observational Study
for
Carcinoma, Non-Small-Cell Lung
Location: Albany NY, Newport News VA, Palm Bay FL, Blacksburg VA,
Sponsor: US Oncology Research
Sex: All
Age: 18+
Code: NCT05885698
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Halifax, Portsmouth NH, Boston MA, East Providence RI,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
for
Cancer
Location: Fairfax VA
Sponsor: Inova Health Care Services
Sex: All
Age: 35 - 70+
Code: NCT06931561
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Guilford CT, New Haven CT, Quebec City, Bay Shore NY,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: New Britain CT, Staten Island NY, Colchester VT,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Halifax, Quebec, Fayetteville NC, Palmetto Bay FL,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All
Age: 18 - 70+
Code: NCT06226883
Phase2, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, Hampton VA, Greenville NC, York PA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase2, Recruiting
Immune Registry for BK in Kidney Transplant Recipients
for
BK Virus Infection, Kidney Transplant; Complications